FDA Inspection 1236398 — GBI USA CO
The FDA completed an inspection of GBI USA CO on Apr 4, 2024 in Sanger, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 4, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Sanger, CA (United States)